Pressmeddelanden

Startup Call Invites New Businesses to Turku, Finland

TurkuScience Park Ltd is organising a programme that invites international startups to develop their businesses in Southwest Finland. In the Startup Call competition, innovative teams participate in an intensive three-month programme that highlights the advantages provided by the startup ecosystem in Turku and Finland.  Applying for the Startup Call programme is now open to all international...

TechTurku Week draws registered participants from 22 countries

Starting next Monday, the TechTurku Week’s programme has already attracted participants from 22 countries. The theme events are arranged in hybrid format, and participating is easy from anywhere in the world. Regarding physical events, the TechTurku Walk visitor tours are almost fully booked. Organised for the 11th time in Turku, Finland, TechTurku Week introduces the technological expertise and...

TechTurku Week Builds Networks Both Locally and Globally

TechTurku Week, which focuses on new technologies, will once again feature many familiar elements, albeit some of them adapted for the new era. Entirely new components are, among others, the TechTurku Walk tours and an evening session for students organised by Boost Turku. TechTurku Week is an annual week of events in early March that showcases the expertise and networks of the Turku region,...

USPTO patent for the Finnish Therapeutica Borealis Ltd.’s COVID-19 drug was granted

Turku-based drug innovation company Therapeutica Borealis Oy has been granted a patent from The United States Patent and Trademark Office (USPTO) for its patent application for a COVID-19 drug. Earlier this month, the company told it had received approval for a patent application, based on which, a final grant was expected during May. It was granted on May 18, 2021, under the patent number...

Finnish Company Therapeutica Borealis Oy has Received USPTO Notice of Allowance for its Covid-19 Drug Patent Application

Turku-based drug innovation company Therapeutica Borealis Oy has received Notice of Allowance from The United States Patent and Trademark Office (USPTO) for its patent application for a Covid-19 drug and the company expects patent to be issued in May 2021. Inventors of the drug and founders of Therapeutica Borealis are Professor Kalervo Väänänen, Adjunct Professor Lauri Kangas and Psychologist...

INVITATION for media conference about new patent for Covid-19 drug

Welcome to media conference, where news about a new patent for Covid-19 drug will be released. Program of the event: The development and potential of the new drug, Kalervo Väänänen, Therapeutica Borealis Oy, Turku, Finland Questions and answers You can join the media conference on 5.5.2021 at 13.00 EET (12.00 CET) via this Teams link.  Welcome! Regional development company Turku Science...

Finnish Life Science Companies on the Frontline in the Fight against COVID-19

The largest and oldest Life Science cluster in Finland operates in the Turku region. The long-term work is now reflected in the ability of numerous companies to respond to the challenges and business opportunities presented by the corona pandemic. In healthcare, the COVID-19 pandemic has created significant new opportunities in both diagnostics and treatment. Over the past two decades, Finland...

Ny svensk skräckserie filmas i Finland under hösten: Nordisk skräck möter high school-drama i Dramacorps Cryptid

Finlands gamla huvudstad Åbo är känd för sina vackra historiska byggnader och en fantastisk skärgård, men i höst förvandlas staden till en plats som ger kalla kårar i en ny svensk serie vid namn Cryptid. Skräckserien för unga vuxna produceras av Dramacorp AB för Viaplay. Cryptid utspelar sig i en liten skandinavisk stad. I samband med att en kedja av fasansfulla och oförklarliga händelser...